Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

Understanding a decade of safety reporting for sacral neuromodulation in the Food and Drug Administration Manufacturer and User Facility Device Experience database.

PMID: 37497812 ·

C, a, i, t, l, i, n, , E, , C, a, r, l, t, o, n, ;, , C, o, l, b, y, , P, , S, o, u, d, e, r, s, ;, , N, a, t, h, a, n, , A, , C, h, e, r, t, a, c, k, ;, , R, a, m, y, , S, , G, o, u, e, l, i, ;, , G, a, r, y, , E, , L, e, m, a, c, k, ;, , J, e, n, n, i, f, e, r, , T, , A, n, g, e, r, ;, , L, y, n, n, , M, c, C, l, e, l, l, a, n, d, ;, , M, a, u, d, e, , E, , C, a, r, m, e, l

RevistaNeurourology and urodynamics
Año
PMID37497812

Resumen

Over 350 000 sacral neuromodulation (SNM) devices have been implanted since approval by the Food and Drug Administration (FDA) in 1998. SNM technology and clinical applications have evolved, with minimal safety updates after initial trials. We aim to provide an updated overview of real-world SNM safety. These insights will guide informed consent, preoperative counseling, and patient expectation-setting. The FDA Manufacturer and User Facility Device Experience (MAUDE) database is a repository for

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑